Phospholipase Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 1462 | AACOCF3 |
| Phospholipase A2 inhibitor | |
| 6316 | ASB 14780 |
| Potent and selective cytosolic phospholipase A2 alpha (cPLA2α) inhibitor; active in vivo; orally bioavailable | |
| 1437 | D609 |
| Selective PC-PLC inhibitor | |
| 6755 | Darapladib |
| Potent lp-PLA2 inhibitor | |
| 7462 | ET 18-OCH3 |
| Selective PI-PLC inhibitor, also PAF receptor agonist | |
| 3600 | FIPI |
| Phospholipase D inhibitor | |
| 7407 | LEI 401 |
| High affinity N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor | |
| 4894 | ML 299 |
| Potent inhibitor of PLD1 and PLD2; CNS penetrant | |
| 1842 | RHC 80267 |
| Diacylglycerol lipase inhibitor. Weak inhibitor of PLC and PLA2 | |
| 1268 | U 73122 |
| Phospholipase C inhibitor | |
| 4133 | U 73343 |
| Analog of U 73122 (Cat. No. 1268) | |
| 3575 | VU 0155069 |
| Potent and selective PLD1 inhibitor | |
| 4171 | VU 0364739 hydrochloride |
| Potent and selective PLD2 inhibitor | |
| 2522 | YM 26734 |
| Secretory phospholipase A2 (sPLA2) inhibitor |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDF